TET1 inhibits EMT of ovarian cancer cells through activating Wnt/beta-catenin signaling inhibitors DKK1 and SFRP2.
Duan H, Yan Z, Chen W, Wu Y, Han J, Guo H, Qiao J
Gynecol Oncol. 2017 Nov;147(2):408-417. doi: 10.1016/j.ygyno.2017.08.010. Epub 2017 Aug 26.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.